Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:19 PM
Ignite Modification Date:
2026-03-26 @ 3:19 PM
NCT ID:
NCT07462260
Eligibility Criteria:
Inclusion Criteria:
1. Patient with diagnosed rheumatic valvular heart disease
2. Age between 18-\> 80 years
3. Severe pulmonary hypertension
Exclusion Criteria:
1. Patient undergoing corrective surgery within 6 weeks
2. Uncontrolled hypertension (\>170/110mmHg)
3. Hypotension (Blood pressure of \< 90/50mmHg)
4. Heart Failure or Coronary Arterial Diseases with Unstable Angina
5. Hypersensitivity to sildenafil or any component of the formulation of sildenafil
6. Prior episode of non-arteritic anterior ischemic neuropathy
7. Stroke in last 6 months
8. Life-threatening arrhythmias
9. MI in last 6 months
10. Patient takes nitrates as essential drug therapy
11. Patient doesn't have a plan for corrective surgery within 6 weeks
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07462260
Study Brief:
Protocol Section:
NCT07462260